Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18887776 | SYSTEM FOR CATHETER-GUIDED VISUALIZATION AND RENDERING | September 2024 | March 2026 | Allow | 18 | 1 | 0 | Yes | No |
| 18741279 | ULTRASONIC DEVICE FOR COUPLING AN ULTRASONIC COUPLING GEL AND ULTRASONIC HEAD | June 2024 | June 2025 | Allow | 12 | 3 | 0 | Yes | No |
| 18689179 | ULTRASOUND IMAGING SYSTEM AND METHOD | March 2024 | August 2025 | Allow | 18 | 1 | 0 | No | No |
| 18438704 | SYSTEM AND METHOD FOR DISPLAY PLANE VISUALIZATION THROUGH AN ULTRASOUND IMAGING VOLUME | February 2024 | February 2026 | Allow | 25 | 2 | 0 | Yes | No |
| 18526848 | DETECTING FLUID FLOWS USING ULTRASOUND IMAGING SYSTEMS | December 2023 | August 2024 | Allow | 8 | 0 | 0 | Yes | No |
| 18508518 | APPARATUS FOR NONINVASIVE VETERINARY SCREENING AND DIAGNOSIS | November 2023 | November 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18447909 | Noninvasive biomarker for diagnosing major depressive disorder using optical coherence tomography | August 2023 | January 2026 | Abandon | 29 | 1 | 1 | Yes | No |
| 18307094 | MAGNETOCARDIOGRAPHY MEASURING APPARATUS | April 2023 | May 2025 | Allow | 25 | 1 | 0 | No | No |
| 18300292 | ULTRASONIC DEVICE FOR COUPLING AN ULTRASONIC COUPLING GEL AND ULTRASONIC HEAD | April 2023 | March 2024 | Allow | 11 | 3 | 0 | Yes | No |
| 18296422 | ULTRASOUND DIAGNOSTIC APPARATUS AND DISPLAY METHOD OF ULTRASOUND DIAGNOSTIC APPARATUS | April 2023 | January 2026 | Allow | 33 | 3 | 0 | Yes | No |
| 18180674 | ULTRASOUND DIAGNOSTIC APPARATUS AND CONTROL METHOD FOR ULTRASOUND DIAGNOSTIC APPARATUS FOR DISPLAYING ULTRASOUND IMAGE AND RADIATION IMAGE | March 2023 | January 2026 | Abandon | 35 | 3 | 0 | Yes | No |
| 18173629 | ULTRASOUND SYSTEM AND CONTROL METHOD OF ULTRASOUND SYSTEM WHICH HAVE FUNCTION OF PREVENTING FORGETTING TO ATTACH PROTECTIVE EQUIPMENT THAT PROTECTS ULTRASOUND PROBE | February 2023 | October 2025 | Allow | 32 | 3 | 0 | Yes | No |
| 18105207 | Intraoperative Ultrasound Probe System and Related Methods | February 2023 | March 2025 | Abandon | 25 | 1 | 0 | No | No |
| 18089013 | SYSTEM AND METHOD FOR AUTOMATICALLY ACQUIRING AND ROTATING AN ULTRASOUND VOLUME BASED ON A LOCALIZED TARGET STRUCTURE | December 2022 | February 2026 | Allow | 37 | 3 | 0 | Yes | No |
| 18146368 | MEDICAL DEVICES AND METHODS THEREOF | December 2022 | July 2025 | Abandon | 31 | 2 | 0 | Yes | No |
| 18074678 | CUSTOMIZED PATIENT TRACKER FOR IMAGE GUIDED SURGERY | December 2022 | February 2026 | Abandon | 38 | 3 | 0 | No | No |
| 17956222 | PORTABLE MEDICAL DEVICE | September 2022 | December 2025 | Abandon | 39 | 4 | 0 | Yes | No |
| 17892718 | MULTI-OBJECT THERMAL RADIATION MEASURING DEVICE AND OPERATING METHOD THEREOF | August 2022 | November 2025 | Abandon | 39 | 2 | 0 | No | No |
| 17877117 | Tracking System | July 2022 | November 2025 | Abandon | 40 | 2 | 0 | Yes | No |
| 17872717 | Large Vessel Occlusion Alert from Optical Measurements | July 2022 | May 2025 | Abandon | 33 | 1 | 0 | No | No |
| 17788416 | DEVICE FOR MONITORING HIFU TREATMENTS | June 2022 | February 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17841489 | Wearable Imaging System for Measuring Bone Displacement | June 2022 | February 2025 | Allow | 32 | 1 | 0 | Yes | No |
| 17831611 | ULTRASOUND IMAGING APPARATUS, ULTRASOUND IMAGING SYSTEM, METHOD OF OPERATING ULTRASOUND IMAGING APPARATUS, COMPUTER-READABLE RECORDING MEDIUM, AND ULTRASOUND ENDOSCOPE SYSTEM | June 2022 | December 2024 | Abandon | 31 | 1 | 0 | Yes | No |
| 17764029 | RECORDING ULTRASOUND IMAGES | March 2022 | February 2025 | Abandon | 34 | 2 | 0 | No | No |
| 17652591 | ULTRASONIC DIAGNOSTIC APPARATUS, DETERMINATION METHOD, AND DETERMINATION PROGRAM | February 2022 | March 2025 | Abandon | 37 | 4 | 0 | Yes | No |
| 17674484 | DISTRIBUTED PORTABLE ULTRASOUND SYSTEM | February 2022 | November 2025 | Allow | 45 | 4 | 0 | No | No |
| 17581439 | Actively Cooled Ultrasound Probe with Additively Manufactured Heat Exchanger | January 2022 | June 2025 | Abandon | 41 | 6 | 0 | Yes | No |
| 17551785 | METHOD AND SYSTEM FOR CAPTURING AND SUMMARIZING CHANGES IN ULTRASOUND SCANNING SETTINGS | December 2021 | April 2024 | Abandon | 28 | 2 | 0 | No | No |
| 17542334 | SPECTRO-MECHANICAL IMAGING FOR CHARACTERIZING EMBEDDED LESIONS | December 2021 | August 2025 | Allow | 44 | 3 | 0 | No | No |
| 17614598 | RELATIVE LOCATION DETERMINING FOR PASSIVE ULTRASOUND SENSORS | November 2021 | December 2025 | Abandon | 48 | 3 | 0 | No | No |
| 17455208 | ULTRASOUND POSITIONING DEVICE, SYSTEM, AND METHOD | November 2021 | November 2024 | Abandon | 36 | 1 | 0 | No | No |
| 17608782 | METHOD AND APPARATUS FOR SHEAR WAVE GENERATION | November 2021 | August 2025 | Abandon | 46 | 4 | 0 | Yes | No |
| 17506180 | METHOD AND SYSTEM FOR CHARACTERIZING VALVULAR REGURGITATION/INSUFFICIENCY FROM SEQUENCES OF IMAGES | October 2021 | December 2024 | Allow | 37 | 3 | 0 | Yes | No |
| 17604941 | ANATOMICAL STRUCTURE IDENTIFICATION APPARATUS AND DISPLAY METHOD THEREOF | October 2021 | October 2024 | Allow | 36 | 4 | 0 | No | No |
| 17412696 | ACTIVELY DAMPED ULTRASONIC TRANSDUCER | August 2021 | January 2025 | Abandon | 40 | 4 | 0 | Yes | No |
| 17430461 | ARTIFICIAL NEURAL NETWORK-BASED NUCLEAR MAGNETIC RESONANCE AND MAGNETIC RESONANCE SPECTROSCOPY DATA PROCESSING METHOD AND APPARATUS THEREOF | August 2021 | July 2025 | Allow | 47 | 3 | 0 | No | No |
| 17393022 | ULTRASOUND PROBE GUIDANCE | August 2021 | July 2025 | Allow | 47 | 7 | 0 | Yes | No |
| 17444336 | METHODS, SYSTEMS, AND DEVICES FOR ANALYZING LUNG IMAGING DATA TO DETERMINE COLLATERAL VENTILATION | August 2021 | March 2024 | Allow | 31 | 1 | 1 | Yes | No |
| 17305603 | ULTRASONIC DIAGNOSTIC APPARATUS AND STORAGE MEDIUM | July 2021 | October 2024 | Abandon | 39 | 4 | 0 | Yes | No |
| 17373015 | APPARATUS AND METHOD FOR ESTIMATING BLOOD PRESSURE | July 2021 | November 2024 | Allow | 40 | 2 | 0 | No | No |
| 17315096 | Automated Three and Four-Dimensional Ultrasound Quantification and Surveillance of Free Fluid in Body Cavities and Intravascular Volume | May 2021 | January 2024 | Abandon | 32 | 2 | 0 | No | No |
| 17239335 | DISPLAYING BLOOD VESSELS IN ULTRASOUND IMAGES | April 2021 | March 2025 | Allow | 47 | 4 | 1 | Yes | No |
| 17237931 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR UTILIZING ULTRASOUND MULTIPLE SCATTERING TO ACCESS PULMONARY FIBROSIS | April 2021 | October 2025 | Allow | 54 | 5 | 0 | Yes | No |
| 17229515 | Methods and Systems for Determining Body Composition of Biological Bodies Using a Resonant Cavity | April 2021 | September 2025 | Abandon | 53 | 3 | 0 | No | No |
| 17205381 | DEFORMATION MODEL FOR A TISSUE | March 2021 | January 2026 | Abandon | 58 | 6 | 0 | Yes | No |
| 17202508 | ELECTRONIC DEVICE, CONTROL METHOD FOR THE ELECTRONIC DEVICE, AND STORAGE MEDIUM | March 2021 | December 2024 | Allow | 45 | 4 | 0 | Yes | No |
| 17195405 | METHOD FOR PROVIDING FRACTURE-DETECTION TOOL | March 2021 | November 2023 | Allow | 32 | 1 | 0 | No | No |
| 17262390 | ULTRASOUND SYSTEM AND METHOD FOR GUIDED SHEAR WAVE ELASTOGRAPHY OF ANISOTROPIC TISSUE | January 2021 | October 2025 | Allow | 57 | 4 | 0 | No | Yes |
| 17132233 | MEDICAL IMAGE DIAGNOSTICS SYSTEM AND ULTRASONIC PROBE | December 2020 | July 2025 | Abandon | 54 | 6 | 1 | No | No |
| 17115966 | METHOD AND APPARATUS FOR QUANTITATIVE IMAGING USING ULTRASOUND DATA | December 2020 | March 2025 | Allow | 51 | 4 | 1 | No | No |
| 16950046 | JOINT ASSESSMENT OF MYOCARDIAL STRAIN AND INTRACARDIAC BLOOD FLOW | November 2020 | October 2024 | Abandon | 47 | 4 | 0 | No | No |
| 17068118 | PROCEDURE VISUALIZATION AND GUIDANCE | October 2020 | October 2025 | Abandon | 60 | 8 | 0 | Yes | No |
| 17062917 | METHOD FOR MAINTAINING LOCALIZATION OF DISTAL CATHETER TIP TO TARGET DURING VENTILATION AND/OR CARDIAC CYCLES | October 2020 | December 2024 | Abandon | 50 | 2 | 0 | Yes | No |
| 17032963 | IMAGE PROCESSING SYSTEM AND CONTROL METHOD THEREOF | September 2020 | October 2025 | Abandon | 60 | 4 | 0 | Yes | No |
| 17003247 | METHOD AND SYSTEM FOR PROVIDING AN ANATOMIC ORIENTATION INDICATOR WITH A PATIENT-SPECIFIC MODEL OF AN ANATOMICAL STRUCTURE OF INTEREST EXTRACTED FROM A THREE-DIMENSIONAL ULTRASOUND VOLUME | August 2020 | January 2024 | Allow | 40 | 4 | 0 | Yes | Yes |
| 16765327 | METHOD AND APPARATUS FOR GUIDING AN ULTRASOUND PROBE | May 2020 | July 2024 | Abandon | 49 | 4 | 0 | Yes | No |
| 16876185 | MATERIAL DECOMPOSITION APPARATUS, PCCT APPARATUS, AND MATERIAL DECOMPOSITION METHOD | May 2020 | December 2023 | Allow | 43 | 3 | 0 | Yes | No |
| 16755334 | TRACKING CONTRAST ELEMENTS IN ULTRASOUND IMAGING | April 2020 | November 2023 | Allow | 46 | 2 | 0 | Yes | No |
| 16645181 | SYSTEM AND METHOD FOR MEASURING REAL-TIME BODY KINEMATICS | March 2020 | September 2025 | Allow | 60 | 6 | 0 | No | No |
| 16805442 | DETECTING FLUID FLOWS USING ULTRASOUND IMAGING SYSTEMS | February 2020 | October 2023 | Allow | 43 | 5 | 0 | Yes | No |
| 16637284 | DEVICE, SYSTEM AND METHOD FOR DETERMINING A PHYSIOLOGICAL PARAMETER OF A SUBJECT | February 2020 | November 2024 | Allow | 57 | 2 | 0 | No | Yes |
| 16741373 | SYSTEM AND METHODS FOR AUTOMATIC LESION CHARACTERIZATION | January 2020 | October 2023 | Allow | 45 | 3 | 1 | No | No |
| 16695974 | METHOD AND DEVICE FOR MEASURING A MEAN VALUE OF VISCO-ELASTICITY OF A REGION OF INTEREST | November 2019 | October 2024 | Allow | 59 | 5 | 0 | Yes | No |
| 16604190 | Laser Line Directional System for 3D Anatomy Ultrasound Phantom Trainer | October 2019 | August 2025 | Abandon | 60 | 5 | 0 | No | Yes |
| 16554138 | AUTOMATED OPTIC NERVE SHEATH DIAMETER MEASUREMENT | August 2019 | August 2024 | Abandon | 60 | 3 | 1 | No | No |
| 16487884 | REMOTELY CONTROLLED ULTRASONIC IMAGING SYSTEM | August 2019 | May 2024 | Abandon | 57 | 6 | 0 | Yes | No |
| 16541955 | SYSTEM OF MACHINE-LEARNING MEDIATED IMAGE ANALYSIS TO AID PREDICTIVE MRI-GUIDED HYPERTHERMIA TREATMENTS | August 2019 | January 2026 | Allow | 60 | 9 | 0 | No | No |
| 16462410 | SYNTHETIC MAGNETIC RESONANCE IMAGING AND MAGNETIC RESONANCE FINGERPRINTING WITH A CONTRAST AGENT, AND DETERMINATION OF A CONTRAST AGENT INJECTION PROTOCOL | May 2019 | January 2024 | Allow | 56 | 5 | 0 | Yes | No |
| 16406630 | DYNAMIC 129Xe GAS EXCHANGE SPECTROSCOPY | May 2019 | November 2023 | Allow | 54 | 3 | 1 | Yes | No |
| 16338884 | X-PLANE AND 3D IMAGING FOR ASYMMETRIC APERTURES | April 2019 | March 2024 | Allow | 59 | 7 | 0 | Yes | No |
| 16373234 | ULTRASOUND DIAGNOSTIC APPARATUS AND ULTRASOUND SIGNAL PROCESSING METHOD | April 2019 | December 2023 | Abandon | 57 | 6 | 0 | Yes | No |
| 16366803 | Radiation Image Processing Apparatus and Radiation Image Processing Method | March 2019 | March 2025 | Abandon | 60 | 6 | 0 | Yes | No |
| 16351075 | ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY USING ULTRASOUND | March 2019 | September 2025 | Abandon | 60 | 10 | 0 | Yes | No |
| 16128191 | SURGICAL VISUALIZATION CONTROLS | September 2018 | January 2026 | Allow | 60 | 9 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BEGEMAN, ANDREW W.
With a 66.7% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 75.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner BEGEMAN, ANDREW W works in Art Unit 3798 and has examined 47 patent applications in our dataset. With an allowance rate of 55.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 49 months.
Examiner BEGEMAN, ANDREW W's allowance rate of 55.3% places them in the 16% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by BEGEMAN, ANDREW W receive 4.28 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by BEGEMAN, ANDREW W is 49 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +0.6% benefit to allowance rate for applications examined by BEGEMAN, ANDREW W. This interview benefit is in the 18% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 14.2% of applications are subsequently allowed. This success rate is in the 10% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 7.1% of cases where such amendments are filed. This entry rate is in the 7% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 24% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 21% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 100.0% are granted (fully or in part). This grant rate is in the 94% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.